These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11111552)

  • 1. Life-threatening illness in a nontransfusable patient: a health care challenge.
    Olivencia G
    Nephrol Nurs J; 2000 Apr; 27(2):237-9. PubMed ID: 11111552
    [No Abstract]   [Full Text] [Related]  

  • 2. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.
    Breiterman-White R
    Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis and acute appendicitis.
    Beasley SW; Meech PR; Neale TJ; Hatfield PJ; Morrison RB
    N Z Med J; 1986 Mar; 99(797):145-6. PubMed ID: 3457290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia management practices in peritoneal dialysis patients. Case study of the anemic patient.
    MacCracken MA
    Nephrol Nurs J; 2001 Aug; 28(4):435-8. PubMed ID: 12143466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and inflammation in patients on dialysis: an underlying contributor to anemia and epoetin alfa hyporesponse.
    Breiterman-White R
    Nephrol Nurs J; 2006; 33(3):319-22; quiz 323-4. PubMed ID: 16859203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus masquerading as CAPD peritonitis.
    Jalil NS; Lee J; Hoffman B; Soloway S
    Adv Perit Dial; 1993; 9():152-5. PubMed ID: 8105911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and anemia: implications for patients on dialysis.
    Breiterman-White R
    Nephrol Nurs J; 2006; 33(5):555-8. PubMed ID: 17044439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing hyporesponse to Epoetin alfa: an algorithm approach: case study of the anemic patient.
    Wingard R
    Nephrol Nurs J; 2000 Oct; 27(5):517-20. PubMed ID: 16649327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non tuberculous mycobacterium peritonitis in continuous ambulatory peritoneal dialysis.
    Youmbissi JT; Malik QT; Ajit SK; al Khursany IA; Rafi A; Karkar A
    J Nephrol; 2001; 14(2):132-5. PubMed ID: 11411016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient.
    Sasak C
    Nephrol Nurs J; 2000 Dec; 27(6):612-5. PubMed ID: 16649342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia: dialysis patients experiences.
    Schatell D; Witten B
    Nephrol News Issues; 2004 Nov; 18(12):49-54. PubMed ID: 15595502
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent abdominal pain caused by a toothpick in a CAPD patient.
    König PS; Kronenberg F; Joannidis M; Dietl P; Lhotta K
    Adv Perit Dial; 1991; 7():96. PubMed ID: 1680466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichosporon beigelii peritonitis in a HIV-positive patient on continuous ambulatory peritoneal dialysis.
    Anuradha S; Chatterjee A; Bajaj J; Singh NP; Agarwal SK; Kaur R
    J Assoc Physicians India; 2000 Oct; 48(10):1022-4. PubMed ID: 11200905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
    Hayslip D
    Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Which dialysis method should be proposed to type 2 diabetics?].
    Ryckelynck JP
    Nephrologie; 2000; 21(4):161-2. PubMed ID: 10976430
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative mortality and epoetin alpha dose among hemodialysis patients.
    Coyne DW
    Am J Kidney Dis; 2008 May; 51(5):866-7; author reply 867. PubMed ID: 18436101
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative mortality and epoetin alpha dose in hemodialysis patients.
    Cotter DJ; Thamer M; Zhang Y
    Am J Kidney Dis; 2008 May; 51(5):865; author reply 865-6. PubMed ID: 18436099
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in managing anemia in patients returning to dialysis after transplant failure.
    Wilson S
    Nephrol Nurs J; 2008; 35(4):383-6. PubMed ID: 18783000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.